A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells
- PMID: 15105835
- DOI: 10.1038/sj.cdd.4401431
A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells
Abstract
In chemosensitive leukemias and solid tumors, anticancer drugs have been shown to induce apoptosis. Deficiencies in the apoptotic pathways may lead to chemoresistance. Here we report that glutathione (GSH) plays a critical role in activation of apoptosis pathways by CD95 (APO-1/Fas) or anticancer drugs. Upon treatment with anticancer drugs or CD95 triggering, CD95-resistant or Bcl-x(L) overexpressing CEM cells were deficient in activation of apoptosis pathways. CD95-resistant and Bcl-x(L) overexpressing CEM cells exhibited higher intracellular GSH levels in comparison to parental cells. Downregulation of GSH by L-buthionine-(S,R)-sulfoxime (BSO), a specific inhibitor of glutathione synthesis, reversed deficiencies in activation of apoptosis pathways by anticancer drugs or CD95. Interestingly, downregulation of GSH by BSO increased CD95 DISC formation in type I cells. In hybrids of CD95-resistant cells with sensitive cells and hybrids of overexpressing Bcl-x(L) cells with sensitive cells, the phenotype of apoptosis resistance was dominant. Also, in these hybrids, downregulation of GSH reversed CD95- and chemoresistance. We conclude that dominant apoptosis resistance depends, at least in part, on intracellular GSH levels, which may affect apoptosis signaling at different compartments, for example, the death receptor or mitochondria.
Similar articles
-
Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.Oncogene. 2001 Mar 1;20(9):1063-75. doi: 10.1038/sj.onc.1204141. Oncogene. 2001. PMID: 11314043
-
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.Oncogene. 2000 Sep 21;19(40):4563-73. doi: 10.1038/sj.onc.1203824. Oncogene. 2000. PMID: 11030145
-
Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.Eur J Pharmacol. 2005 Aug 22;518(2-3):96-106. doi: 10.1016/j.ejphar.2005.06.021. Eur J Pharmacol. 2005. PMID: 16054126
-
Mechanisms of resistance to TRAIL-induced apoptosis in cancer.Cancer Gene Ther. 2005 Mar;12(3):228-37. doi: 10.1038/sj.cgt.7700792. Cancer Gene Ther. 2005. PMID: 15550937 Review.
-
Death receptors leave a caspase footprint that Smacs of XIAP.Cell Death Differ. 2003 Jan;10(1):4-6. doi: 10.1038/sj.cdd.4401176. Cell Death Differ. 2003. PMID: 12655287 Review. No abstract available.
Cited by
-
Cell death sensitization of leukemia cells by opioid receptor activation.Oncotarget. 2013 May;4(5):677-90. doi: 10.18632/oncotarget.952. Oncotarget. 2013. PMID: 23633472 Free PMC article.
-
Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma.J Transl Med. 2024 Aug 28;22(1):792. doi: 10.1186/s12967-024-05545-5. J Transl Med. 2024. PMID: 39198815 Free PMC article.
-
GSH-dependent regulation of Fas-mediated caspase-8 activation by acrolein.FEBS Lett. 2007 Feb 6;581(3):361-7. doi: 10.1016/j.febslet.2006.12.040. Epub 2007 Jan 12. FEBS Lett. 2007. PMID: 17222828 Free PMC article.
-
Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach.Metabolites. 2019 Mar 13;9(3):50. doi: 10.3390/metabo9030050. Metabolites. 2019. PMID: 30871192 Free PMC article.
-
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.Blood. 2008 Sep 1;112(5):1912-22. doi: 10.1182/blood-2008-04-149815. Epub 2008 Jun 23. Blood. 2008. PMID: 18574029 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
